Heska To Roll Out Sublingual Allergy Therapy For Pets

Heska Corp. will manufacture and market a proprietary, sublingual therapy treatment for pet allergies.

Heska Corp. plans to manufacture and market a proprietary, sublingual therapy treatment for pets suffering with allergies, the company announced today.

The Loveland, Colo.-based company will introduce the new product at the onset of the allergy season.

Dr. Mary Morris and Associates LLC of La Crosse, Wis., developed the therapy treatment to expand treatment options for allergic diseases in people and animals, and partnered with Heska Corp. to manufacture and market the technology to the pet market.

“Sublingual therapy offers a convenient alternative to subcutaneous injection, thereby enhancing the likelihood of pet owner compliance,” said Michael McGinley, president and chief operating officer of Heska.

The product has undergone substantial testing over the past three years, according to Heska.

Heska will manufacture the new allergy treatment product at its Des Moines, Iowa, facility, where the company moved its allergy immunotherapy manufacturing in 2011.


Leave a Comment


Your email address will not be published. Required fields are marked *



Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.